Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sensory profile of two new nicotine transdermal patches vs Nicotinell TTS 21 mg/24h
2007-006458-24Phase 2Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of nicotine in nicotine dependence (3 arms), sponsored by Pierre Fabre Laboratories. Primary endpoints: Sensory characteristics rating and Local clinical tolerability. Started Aug 2010; status: completed.
02
Drugs
nicotine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on 2007-006458-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006458-24.